Spots Global Cancer Trial Database for chimeric antigen receptor modified t cells targeting cd19
Every month we try and update this database with for chimeric antigen receptor modified t cells targeting cd19 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma | NCT02349698 | Leukemia Lymphoma | Chimeric Antige... | 4 Years - 75 Years | Southwest Hospital, China | |
| A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma | NCT02349698 | Leukemia Lymphoma | Chimeric Antige... | 4 Years - 75 Years | Southwest Hospital, China |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
